36
Views
17
CrossRef citations to date
0
Altmetric
Miscellaneous

A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule

Pages 1559-1566 | Published online: 24 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Aamir Saleem, Asghar Qasim, Humphrey J O’Connor & Colm A O’Morain. (2009) Pylera® for the eradication of Helicobacter pylori infection. Expert Review of Anti-infective Therapy 7:7, pages 793-799.
Read now
Rino Rappuoli, Duccio Berti, Samuele Peppoloni, Giuseppe Del Giudice & Paolo Ruggiero. (2002) New strategies for the prevention and treatment of Helicobacter pylori infection. Expert Opinion on Investigational Drugs 11:8, pages 1127-1138.
Read now

Articles from other publishers (15)

Yi Zhou, Jiang Jiang, Fulong Gu & Daguo Mi. (2022) Comparison of Therapeutic Effects of PVP and PKP Combined With Triple Medication on Mild and Moderate Osteoporotic Vertebral Compression Fracture in the Elderly. Frontiers in Surgery 8.
Crossref
Olga P. Nyssen, Adrian G. McNicholl & Javier P. Gisbert. (2019) Meta‐analysis of three‐in‐one single capsule bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori . Helicobacter 24:2, pages e12570.
Crossref
Amelia Brigandì, Vincenzo Rizzo, Vanessa Ziccone & Paolo Girlanda. (2018) Bismuth-related acute neurotoxicity as stroke mimic: a case report. Neurological Sciences 40:3, pages 653-654.
Crossref
Vasilios Papastergiou. (2014) Treatment of Helicobacter pylori infection: Meeting the challenge of antimicrobial resistance . World Journal of Gastroenterology 20:29, pages 9898.
Crossref
Francis Mégraud. (2012) The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy . Therapeutic Advances in Gastroenterology 5:2, pages 103-109.
Crossref
Sotirios D. Georgopoulos, Vasilios Papastergiou & Stylianos Karatapanis. (2012) Helicobacter    pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy . Gastroenterology Research and Practice 2012, pages 1-9.
Crossref
J. P. Gisbert & X. Calvet. (2011) Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori. Alimentary Pharmacology & Therapeutics 34:6, pages 604-617.
Crossref
Javier P. Gisbert, Xavier Calvet, Anthony O'Connor, Francis Mégraud & Colm A. O'Morain. (2010) Sequential Therapy for Helicobacter pylori Eradication. Journal of Clinical Gastroenterology 44:5, pages 313-325.
Crossref
Saeed Ahmad, Anvarhusein A. Isab, Saqib Ali & Abdul Rahman Al-Arfaj. (2006) Perspectives in bioinorganic chemistry of some metal based therapeutic agents. Polyhedron 25:7, pages 1633-1645.
Crossref
Rong Chen, Man Ho So, Jun Yang, Feng Deng, Chi-Ming Che & Hongzhe Sun. (2006) Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate. Chemical Communications:21, pages 2265.
Crossref
W.A. de Boer, E.J. Kuipers & J.G. Kusters. (2004) Sequential therapy; a new treatment for Helicobacter pylori infection. Digestive and Liver Disease 36:5, pages 311-314.
Crossref
Wei Li, Lan Jin, Nianyong Zhu, Xuemei Hou, Feng Deng & Hongzhe Sun. (2003) Structure of Colloidal Bismuth Subcitrate (CBS) in Dilute HCl:  Unique Assembly of Bismuth Citrate Dinuclear Units ([Bi(cit) 2 Bi] 2- ) . Journal of the American Chemical Society 125:41, pages 12408-12409.
Crossref
C. O'Morain, T. Borody, A. Farley, W. A. De Boer, C. Dallaire, R. Schuman, J. Piotrowski, C. A. Fallone, G. Tytgat, F. Mégraud & J. Spénard. (2003) Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori : an international multicentre study . Alimentary Pharmacology & Therapeutics 17:3, pages 415-420.
Crossref
C. Nash, L. Fischbach & S. Veldhuyzen van Zanten. 2003. Helicobactor pylori. Helicobactor pylori 329 338 .
Franco Bazzoli, Paolo Pozzato & Theodore Rokkas. (2002) Helicobacter pylori: the challenge in therapy. Helicobacter 7:s1, pages 43-49.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.